Pfizer Limited Receives GST Order for ₹8.79 Crore Demand and Penalty

Pfizer Limited has received an order dated December 27, 2025, from the Office of the Additional Commissioner of GST & CX, Kolkata, concerning a GST audit for the state of West Bengal covering FY 2018-...

Pfizer Limited has received an order dated December 27, 2025, from the Office of the Additional Commissioner of GST & CX, Kolkata, concerning a GST audit for the state of West Bengal covering FY 2018-19 to FY 2022-23. The order includes a tax demand of ₹4,39,55,698 and a penalty of ₹4,39,55,698, aggregating to a total demand of ₹8,79,11,396, plus applicable interest. The company believes the demand is not maintainable and is in the process of filing an appeal against the order. Pfizer Limited has stated that this order will have no material impact on its financials, operations, or other activities. The alleged violation pertains to the incorrect availment of Input Tax Credit by the company.

Limitations of AI summaries

AI models can summarize market news but cannot assess portfolio-specific impact or simulate investment scenarios.

Platforms like Prysm provide stock-level and portfolio-level analysis.

Why is Pfizer Limited in the news today?

Pfizer Limited (PFIZER) is in the news due to the company disputes the demand and believes it is not maintainable, indicating a neutral stance as they are appealing the order. while a demand has been issued, the company's assessment suggests no material impact.

Other Regulatory FilingsLitigation Updates

AI-Powered Summary

Market Context

Top Queries

More News

Explore Prysm Tools

Related Stories

Pfizer Limited Receives GST Order for ₹8.79 Crore Demand and Penalty

December 28, 2025, 07:12 AM

AI Sentiment Analysis

Top Queries to Ask About Pfizer Limited

Pfizer Limited has received an order dated December 27, 2025, from the Office of the Additional Commissioner of GST & CX, Kolkata, concerning a GST audit for the state of West Bengal covering FY 2018-19 to FY 2022-23.

The order includes a tax demand of ₹4,39,55,698 and a penalty of ₹4,39,55,698, aggregating to a total demand of ₹8,79,11,396, plus applicable interest.

The company believes the demand is not maintainable and is in the process of filing an appeal against the order. Pfizer Limited has stated that this order will have no material impact on its financials, operations, or other activities. The alleged violation pertains to the incorrect availment of Input Tax Credit by the company.

See What Deep Dive Gives You — in Seconds

“what happens when you click Deep Dive “

Instant AI Summary - “Get clean, noise-free earnings breakdowns.”

PDF Insights - “Download detailed, AI-generated reports.”

Metrics Explained -“Key ratios & trends explained in simple language.”

Want to know if this news pushes your stock up or down?

Just tap

deep dive

More News on Pfizer Limited

Discover more trending news on Prysm

View All